Delivery Order SPE2DB20D1100-SPE2DB24FD2T2

Award Date 8/14/24
Potential Completion Date 9/5/24
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,170.72, is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product, with a period of performance through November 15, 2024. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $10,947.00, is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical supplies. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML. The contract is a Delivery Order valued at $21,163.20 with a fixed-price pricing type and a completion date of July 29, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award, valued at $18,245.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award, valued at $3,649.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product, with a completion date of December 11, 2024. This contract award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $18,245.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product, with a completion date of May 9, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product. The $8,818.00 firm-fixed price delivery order contract has a performance period through May 23, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a key agency within the Department of Defense, to the prime contractor Amerisourcebergen Drug Corp. The $3,527.20 firm-fixed-price delivery order is for the medical product "GEL-ONE 30 MG/3 ML SYRINGE 3ML" and has a period of performance through November 7, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $18,245.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML, with a completion date of June 26, 2025. This is a Firm Fixed Price delivery order contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,245.00 Firm Fixed Price Delivery Order is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product used in healthcare settings. The contract has an ultimate completion date of March 12, 2025 and was awarded on February 19, 2025. This award is associated with a larger Indefinite Delivery Contract...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD2T2
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical supplies. The award is a Delivery Order with a Firm Fixed Price valued at $21,163.20 and has a completion date of September 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract award does not have a set-aside designation.

Generated 11/13/24, 9:21 AM